Fig. 1 · Structure
Documents & Downloads
Dihydroartemisinin (mixture of α and β isomers)
Anticancer Agent
Dihydroartemisinin (mixture of α and β isomers) primarily targets cancer cells by inducing apoptosis and inhibiting proliferation, metastasis, and angiogenesis. As an active metabolite of artemisinin, it showcases significant anticancer activity through diverse molecular mechanisms, including the promotion of immune function, autophagy, and endoplasmic reticulum stress. This compound is utilized in cancer research to explore innovative therapeutic strategies and enhance our understanding of tumor biology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 131175-87-6 |
| Applications | Anticancer Agent |
| Formula | C15H24O5 |
| Molecular Weight | 284.35 |
| Synonyms | Dihydroartemisinin (α,β mixture) |
| SMILES | C[C@@H]1[C@@]2([H])[C@]34[C@@](OC1O)([H])O[C@](OO3)(CC[C@@]4([H])[C@@H](CC2)C)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.